NA
TMDX icon

NewEdge Advisors’s Transmedics TMDX Stock Holding History

NewEdge Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Buy
190
+64
+51% +$5.42K ﹤0.01% 3483
2026
Q1 		$12.5K Sell
126
-69
-35% -$9K ﹤0.01% 3335
2025
Q4 		$23.7K Hold
195
– – ﹤0.01% 3195
2025
Q3 		$21.9K Sell
195
-11,117
-98% -$1.3M ﹤0.01% 3096
2025
Q2 		$1.52M Sell
11,312
-11,980
-51% -$1.32M 0.01% 1065
2025
Q1 		$1.57M Sell
23,292
-1,343
-5% -$92.4K 0.01% 967
2024
Q4 		$1.54M Buy
24,635
+11,406
+86% +$1.06M 0.01% 947
2024
Q3 		$2.08M Buy
13,229
+2,857
+28% +$440K 0.01% 779
2024
Q2 		$1.56M Buy
10,372
+2,140
+26% +$257K 0.01% 864
2024
Q1 		$609K Buy
8,232
+7,087
+619% +$584K 0.01% 1230
2023
Q4 		$90.4K Buy
1,145
+71
+7% +$4.28K ﹤0.01% 1984
2023
Q3 		$58.8K Sell
1,074
-545
-34% -$39.2K ﹤0.01% 2043
2023
Q2 		$136K Sell
1,619
-10,029
-86% -$768K ﹤0.01% 1755
2023
Q1 		$882K Sell
11,648
-3,708
-24% -$256K 0.01% 836
2022
Q4 		$35.6K Buy
15,356
+664
+5% +$35.3K ﹤0.01% 1868
2022
Q3 		$613K Buy
+14,692
New +$639K 0.01% 873

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

NewEdge Advisors's TMDX Position: Q2 2026 in Review

NewEdge Advisors increased its Transmedics (TMDX) stake by 51% in Q2 2026, buying an estimated $5.42K and bringing the position to 190 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3483.

NewEdge Advisors first reported a position in TMDX in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.08M in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • NewEdge Advisors held 190 shares of Transmedics worth $12.6K as of Q2 2026.
  • NewEdge Advisors bought 64 Transmedics shares in Q2 2026, an estimated $5.42K.
  • Transmedics made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3483 holding.
  • NewEdge Advisors first reported a position in Transmedics in Q3 2022 and has held it in 16 quarters since.
  • NewEdge Advisors's Transmedics position peaked at $2.08M in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.